BOLERO1_2B | R Documentation |
Kaplan-Meier digitized data from BOLERO1, figure 2B (PMID 26092818). A reported sample size of 719 for a primary endpoint of PFS(overall & HR- population) in breast cancer.
BOLERO1_2B
A data frame of 719 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (everolimus, placebo) | |
Hurvitz SA, Andre F, Jiang Z, et al. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial. Lancet Oncol 2015; 16: 816–29.
summary(BOLERO1_2B)
kmplot(BOLERO1_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.